Skip to Main Content

Author Details

Pedro J Caraballo
Mayo Clinic
1999
68
21
PMIDPaper TitleJournal TitlePublished Year
36691060Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design.Cardiooncology2023
37373918Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia.J Pers Med2023
36621880Returning integrated genomic risk and clinical recommendations: The eMERGE study.Genet Med2023
35331649Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.Genet Med2022
35434676Establishing an interdisciplinary research team for cardio-oncology artificial intelligence informatics precision and health equity.Am Heart J Plus2022
34065005Preferences for Updates on General Research Results: A Survey of Participants in Genomic Research from Two Institutions.J Pers Med2021
33538610Pharmacogenomics education and perceptions: is there a gap between internal medicine resident and attending physicians?Pharmacogenomics2021
33930535Genomic considerations for FHIR®; eMERGE implementation lessons.J Biomed Inform2021
34697394A novel method for causal structure discovery from EHR data and its application to type-2 diabetes mellitus.Sci Rep2021
34747639Pharmacogenomics testing in patients with liver transplant and potential impact on prospective management.Pharmacogenomics2021
34129510A Computational Method for Learning Disease Trajectories From Partially Observable EHR Data.IEEE J Biomed Health Inform2021
34242241Association of BMI, comorbidities and all-cause mortality by using a baseline mortality risk model.PLoS One2021
31591640Integrating pharmacogenomics into the electronic health record by implementing genomic indicators.J Am Med Inform Assoc2020
36644330Deploying Clinical Decision Support for Familial Hypercholesterolemia.ACI open2020
31914992Predicting diabetes clinical outcomes using longitudinal risk factor trajectories.BMC Med Inform Decis Mak2020
32717811An Implementation Science Framework to Develop a Clinical Decision Support Tool for Familial Hypercholesterolemia.J Pers Med2020
32678448Development and Validation of a Risk Stratification Model Using Disease Severity Hierarchy for Mortality or Major Cardiovascular Event.JAMA Netw Open2020
32377377Challenges in returning results in a genomic medicine implementation study: the Return of Actionable Variants Empirical (RAVE) study.NPJ Genom Med2020
31378813Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol).Int J Epidemiol2020
30590574Pharmacogenomic clinical decision support design and multi-site process outcomes analysis in the eMERGE Network.J Am Med Inform Assoc2019
31802928Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare.Pharmgenomics Pers Med2019
33313606Frequent Causal Pattern Mining: A Computationally Efficient Framework For Estimating Bias-Corrected Effects.Proc IEEE Int Conf Big Data2019
31438273Impact of the Performance Gap Between Interactive Alerts and Quality Metrics.Stud Health Technol Inform2019
31437931Evaluating the Impact of Data Representation on EHR-Based Analytic Tasks.Stud Health Technol Inform2019
31098679Towards more Accessible Precision Medicine: Building a more Transferable Machine Learning Model to Support Prognostic Decisions for Micro- and Macrovascular Complications of Type 2 Diabetes Mellitus.J Med Syst2019
30865535CLINICAL RECOGNITION AND MANAGEMENT OF PATIENTS WITH PREDIABETES.Endocr Pract2019
29218905Considerations for automated machine learning in clinical metabolic profiling: Altered homocysteine plasma concentration associated with metformin exposure.Pac Symp Biocomput2018
29888055Multi-Task Learning to Identify Outcome-Specific Risk Factors that Distinguish Individual Micro and Macrovascular Complications of Type 2 Diabetes.AMIA Jt Summits Transl Sci Proc2018
29860405Empowering genomic medicine by establishing critical sequencing result data flows: the eMERGE example.J Am Med Inform Assoc2018
30225440A Clinical Decision Support Tool for Familial Hypercholesterolemia Based on Physician Input.Mayo Clin Proc Innov Qual Outcomes2018
30392543The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results.Mayo Clin Proc2018
29436466Evaluation of prescriber responses to pharmacogenomics clinical decision support for thiopurine <i>S</i>-methyltransferase testing.Am J Health Syst Pharm2018
29107482Prevalence and Outcome of High-Risk QT Prolongation Recorded in the Emergency Department from an Institution-Wide QT Alert System.J Emerg Med2018
27657685Multidisciplinary model to implement pharmacogenomics at the point of care.Genet Med2017
29862384Estimating Disease Onset Time by Modeling Lab Result Trajectories via Bayes Networks.IEEE Int Conf Healthc Inform2017
28390138Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.Clin Pharmacol Ther2017
28429460Automated T-wave analysis can differentiate acquired QT prolongation from congenital long QT syndrome.Ann Noninvasive Electrocardiol2017
29295340Technical Challenges and Opportunities when Implementing Pharmacogenomics Decision Support Integrated in the Electronic Health Record.Stud Health Technol Inform2017
28949250The challenges of implementing pharmacogenomic testing in the clinic.Expert Rev Pharmacoecon Outcomes Res2017
28769582<i>CYP2D6</i> phenotypes are associated with adverse outcomes related to opioid medications.Pharmgenomics Pers Med2017
28866768Providers' Response to Clinical Decision Support for QT Prolonging Drugs.J Med Syst2017
28757317Challenges in Ordering and Interpreting Pharmacogenomic Tests in Clinical Practice.Am J Med2017
28055020Participant-perceived understanding and perspectives on pharmacogenomics: the Mayo Clinic RIGHT protocol (Right Drug, Right Dose, Right Time).Genet Med2017
27779246Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?Pharmacogenomics J2017
26947514Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.J Mol Diagn2016
27158565Type 2 Diabetes Mellitus Trajectories and Associated Risks.Big Data2016
27155109Integrating Pharmacogenomics into Clinical Practice: Promise vs Reality.Am J Med2016
26850412Statin Use, Diabetes Incidence and Overall Mortality in Normoglycemic and Impaired Fasting Glucose Patients.J Gen Intern Med2016
25324555Impact of clinical decision support preventing the use of QT-prolonging medications for patients at risk for torsade de pointes.J Am Med Inform Assoc2015
26409639Frequency and cause of transient QT prolongation after surgery.Am J Cardiol2015
  • 1 - 50 of 68

Recommended Authors

Columbia University
Career Start Year 2015
Number of shared co-authors 5
University of Florida Health
Career Start Year 2014
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 2012
Number of shared co-authors 3
Vanderbilt University Medical Center
Career Start Year 2010
Number of shared co-authors 6
Columbia University Irving Medical Center
Career Start Year 2010
Number of shared co-authors 6
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 15
University of Toronto
Career Start Year 2007
Number of shared co-authors 0
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2006
Number of shared co-authors 3
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 2
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 2
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 3
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 4
St. Jude Children's Research Hospital Memphis
Career Start Year 2003
Number of shared co-authors 14
Georgia Tech Research Institute, Georgia Tech College of Computing
Career Start Year 2002
Number of shared co-authors 1
Stanford University
Career Start Year 2002
Number of shared co-authors 10
University of Minnesota, Institute for Health Informatics.
Career Start Year 2002
Number of shared co-authors 3
University of California los angeles
Career Start Year 2001
Number of shared co-authors 5
University of Missouri School of Medicine, PCORnet Clinical Research Network
Career Start Year 2000
Number of shared co-authors 7
University of Utah, USA University of Utah Health
Career Start Year 1998
Number of shared co-authors 17
Fox Chase Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Hospital Medicine Unit, Brigham and Women's Hospital
Career Start Year 1997
Number of shared co-authors 1
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 5
Brigham and Women's Hospital
Career Start Year 1996
Number of shared co-authors 2
University of Pennsylvania Perelman School of Medicine
Career Start Year 1996
Number of shared co-authors 8
University of Florida
Career Start Year 1995
Number of shared co-authors 10
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Career Start Year 1991
Number of shared co-authors 10
University of Illinois Chicago
Career Start Year 1989
Number of shared co-authors 4
Stanford University
Career Start Year 1989
Number of shared co-authors 2
Brigham and Women's Hospital Division of General Internal Medicine
Career Start Year 1988
Number of shared co-authors 11
Weill Cornell Medical College
Career Start Year 1987
Number of shared co-authors 13

Collaborators

Institute for Health Informatics, University of Minnesota
Co-authored papers 17
Mayo Clinic
Co-authored papers 15
Mayo Clinic
Co-authored papers 15
Center for Individualized Medicine, College of Medicine, Mayo Clinic
Co-authored papers 11
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 10
Mayo Clinic
Co-authored papers 9
Mayo Clinic
Co-authored papers 8
Mayo Clinic, Windland Smith Rice Genetic Heart Rhythm Clinic)
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 7
Mayo Clinic, Windland Smith Rice Genetic Heart Rhythm Clinic)
Co-authored papers 7
Biomedical Ethics, Mayo Clinic and Foundation
Co-authored papers 6
National Heart Lung and Blood Institute
Co-authored papers 6
Brown University, Brown University Warren Alpert Medical School, Dartmouth-Hitchcock Medical Center, Harvard School of Public Health, Johns Hopkins Medicine, Mayo Clinic Minnesota
Co-authored papers 6
Mayo Clinic
Co-authored papers 5
Baylor College of Medicine
Co-authored papers 5
Mayo Clinic
Co-authored papers 5
Center for Individualized Medicine
Co-authored papers 4
Baylor College of Medicine
Co-authored papers 4
Northwestern University Feinberg School of Medicine
Co-authored papers 4
Vanderbilt University Medical Center
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
Arizona State University
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
Biomedical Ethics Program, Mayo Clinic
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
Mayo Clinic
Co-authored papers 3